This digest covers key virtual and digital health regulatory and public policy developments during October 2023 from the United States, United Kingdom, and European Union.
This digest covers key virtual and digital health regulatory and public policy developments during October 2023 from the United States, United Kingdom, and European Union.
On October 19, 2023, the U.S. Food and Drug Administration (FDA) issued Guidance for Industry and FDA Staff titled Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring (guidance).
In the wake of the Department of Health and Human Services' (HHS) February announcement that they will be discontinuing the COVID-19 public health emergency (PHE) declaration on May 11, 2023.